作者：
Zuliang,Jie [1]
;
Jin-Young,Yang [1]
;
Meidi,Gu [1]
;
Hui,Wang [1]
;
Xiaoping,Xie [2]
;
Yanchuan,Li [1]
;
Ting,Liu [1]
;
Lele,Zhu [1]
;
Jianhong,Shi [3]
;
Lingyun,Zhang [1]
;
Xiaofei,Zhou [1]
;
Donghyun,Joo [4]
;
Hans D,Brightbill [1]
;
Yingzi,Cong [5]
;
Daniel,Lin [1]
;
Xuhong,Cheng [1]
;
Shao-Cong,Sun [6]
作者单位：
Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[1]
Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, China.
[2]
Department of Laboratory Medicine, West China Second University Hospital, State Key Laboratory of Biotherapy and Collaborative Innovation Center for Biotherapy, Sichuan University, Chengdu, China.
[3]
Central Laboratory, Affiliated Hospital of Hebei University, Baoding, China.
[4]
Center for Reproductive Medicine, Henan Key Laboratory of Reproduction and Genetics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
[5]
Department of Immunology, Genentech, Inc., South San Francisco, CA, USA.
[6]
Department of Pathology and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
[7]
Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ssun@mdanderson.org.
[8]
MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, Houston, TX, USA. ssun@mdanderson.org.
[9]
DOI
10.1038/s41590-018-0206-z
PMID
30250187
发布时间
2023-12-13
换一批
换一批
